Bosutinib

Category: Cancer



Bosutinib Overview

Bosutinib (rINN/USAN; codenamed SKI-606, marketed under the trade name Bosulif) is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. Originally synthesized by Wyeth, it is being developed by Pfizer. Contents 1 Mechanism 2 Medical uses 3 Adverse effects 3.1 Contraindications 3.2 Interactions 3.3 Carcinogenicity and mutagenicity 4 Quality issues 5 Notes 6 See also 7 References 8 External links Mechanism It is an ATP-c...

Read more Bosutinib Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bosutinib

Recent Bosutinib Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Bosutinib
  • Tablet: 100mg, 400mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Bosutinib or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA